Evaluation of inundative releases of Eretmocerus eremicus and Encarsia formosa Beltsville strain in commercial greenhouses for control of Bemisia argentifolii (Hemiptera : Aleyrodidae) on poinsettia stock plants
Ms. Hoddle et Rg. Van Driesche, Evaluation of inundative releases of Eretmocerus eremicus and Encarsia formosa Beltsville strain in commercial greenhouses for control of Bemisia argentifolii (Hemiptera : Aleyrodidae) on poinsettia stock plants, J ECON ENT, 92(4), 1999, pp. 811-824
The effectiveness of weekly inundative releases of 3 female Eretmocerus ere
micus (evaluated in 2 greenhouses) and 4-7 Encarsia formosa Beltsville stra
in (evaluated in 2 greenhouses) per plant for control of Bemisia argentifol
ii Bellows & Perring [ =Bemisia tabaci (Gennadius) strain B (Bellows et al.
1994)] (Homoptera: Aleyrodidae) on poinsettia stock plants was determined
under commercial growing conditions. We constructed partial life-tables for
B. argentifolii in the presence and absence of parasitoids in each of 4 gr
eenhouses to quantify parasitoid impact. Weekly population counts of B, arg
entifolii were also made. Initial starting densities of live B. argentifoli
i nymphs and pupae on cuttings used for the stock plant crop ranged from 0.
25 to 1.86. Each site where each parasitoid species was tested had 1 relati
vely low and high initial starting density of B. argentifolii. Under these
conditions, E. eremicus effectively controlled B. argentifolii at 2 sites a
nd cuttings were harvested with 0.656-1.49 live nymphs and pupae per leaf w
ithout insecticide use. Trials with E. formosa Beltsville strain were termi
nated early at 2 sites and insecticides were applied before the harvesting
of cuttings because this parasitoid failed to control B, argentifolii altho
ugh initial starting densities of B. argentifolii were similar to those in
E. eremicus greenhouses. The cost of using E. eremicus was compared with th
e cost of the insecticide imidacloprid for B. argentifolii control at 1 sit
e. At a retail cost of $22 per 1,000 parasitoids in 1995, the use of E. ere
micus was 44 times more expensive than imidacloprid.